Results 21 to 30 of about 88,220 (256)
Multimodality Treatment with Conventional Transcatheter Arterial Chemoembolization and Radiofrequency Ablation for Unresectable Hepatocellular Carcinoma [PDF]
, 2011 Background/Aims: To evaluate the efficacy of multimodality treatment consisting of conventional transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) in patients with non-resectable and non-ablatable hepatocellular carcinoma ...
Rentsch, M. +15 more
core +1 more source
Diagnosis and Treatment for Hepatocellular Tumors
, 2023 Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer, accounting for >80% of primary liver cancers worldwide. The diagnosis of HCC, relying solely on noninvasive criteria, is currently under debate due to the need for molecular ...
core +1 more source
kongfen520/RNA-seq-for-HCC-patient: RNA-seq-for-HCC-patient
, 2020 RNA-seq for HCC ...
kongfen520
core +1 more source
The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma
Cancer Biology & Medicine, 2022 The Wnt/β-catenin signaling pathway regulates many aspects of tumor biology, and many studies have focused on the role of this signaling pathway in tumor cells.
Kaiting Wang +4 more
doaj +1 more source
Mechanism and Role of circRNA in Occurrence and Development of Hepatocellular Carcinoma
Zhongliu Fangzhi Yanjiu, 2022 Hepatocellular carcinoma (HCC) is the most common pathological type of primary liver cancer, with high fatality rate. The pathogenesis of HCC is complex, and the specific occurrence and development mechanism is still in the exploratory stage.
ZHOU Hong +6 more
doaj +1 more source
Breastfeeding as Protective Nutrition: The Immunological Foundation for Infants
Amerta NutritionBackground: Breastfeeding, a crucial foundation for infant health, provides essential protective nutrition and a complex array of immune-protective factors.
Bunga Pelangi +3 more
doaj +1 more source
World Journal of Nuclear Medicine, 2018 Prostate-specific membrane antigen (PSMA) is a glycosylated type-II transmembrane protein highly expressed in certain tumor cells. To the best of our knowledge, this is the first case reported of an isolated well-differentiated hepatocellular carcinoma ...
Hian Huang +2 more
doaj +1 more source
Current Hepatology Reports, 2020 Hepatocellular carcinoma (HCC) is a leading cause of cancer related mortality in the world and it has limited treatment options. Understanding the molecular drivers of HCC is important to develop novel biomarkers and therapeutics.HCC arises in a complex background of chronic hepatitis, fibrosis and liver regeneration which lead to genomic changes. Here,
Nia Adeniji, Renumathy Dhanasekaran
openaire +3 more sources
Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa. [PDF]
, 2010 The main objectives of this study were to define the occurrence and levels of hepatitis B virus (HBV) DNA in asymptomatic HBV carriers, cirrhosis patients and hepatocellular carcinoma (HCC) cases from The Gambia, and to evaluate the risk for cirrhosis or
Whittle, H +23 more
core +1 more source
NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL
Фармакоэкономика, 2015 Introduction. Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as an important and common public health problem that can lead to cirrhosis and hepatic failure (hepatocellular carcinoma – HCC).
D. V. Blinov
doaj +1 more source